...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Surgical Endoscopy >Laparoscopic approach for treatment of multiple hepatocellular carcinomas
【24h】

Laparoscopic approach for treatment of multiple hepatocellular carcinomas

机译：腹腔镜治疗多发性肝细胞癌

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Background: The aim of this study is to evaluate clinical and oncologic outcomes after laparoscopic surgery for patients with multiple hepatocellular carcinoma (HCC). Methods: Among the 260 patients who underwent laparoscopic procedures, including laparoscopic liver resection and laparoscopic radiofrequency ablation (LRFA), between September 2003 and December 2009, 107 patients with HCC were included in this retrospective study. According to tumor multiplicity, patients were divided into multiple lesion (n = 23) and single lesion (n = 84) groups. We compared the operative outcomes after the laparoscopic procedures between the single and multiple tumor groups. Results: There was no difference in the clinicopathologic characteristics between the two groups, except the multiple group had more frequent previous history of preoperative transarterial chemoembolization. LRFA was more frequently used in the multiple group as compared with the single group. There was no postoperative mortality in either group. Application of laparoscopic surgery in the multiple group did not increase the operative time, rate of intraoperative transfusion, length of postoperative hospital stay, or postoperative complications, as compared with the single group. After median follow-up of 33.7 months, there was no statistically significant difference of the survival rates between the two groups, although there was a better disease-free survival rate in the single group. Conclusions: This study shows that laparoscopic surgery, including LH and LRFA, can be safely applied to patients with multiple HCCs, and the survival outcomes are acceptable.
机译：背景：本研究的目的是评估腹腔镜手术后多发性肝细胞癌（HCC）患者的临床和肿瘤学结局。方法：回顾性研究2003年9月至2009年12月间260例行腹腔镜手术的患者，包括腹腔镜肝切除术和腹腔镜射频消融术（LRFA），其中包括107例HCC患者。根据肿瘤的多样性，将患者分为多灶（n = 23）和单灶（n = 84）组。我们比较了单个和多个肿瘤组在腹腔镜手术后的手术效果。结果：两组之间的临床病理特征没有差异，只是多组术前经动脉化疗栓塞的病史更为频繁。与单组相比，LRFA在多组中使用更为频繁。两组均无术后死亡率。与单组相比，多组腹腔镜手术的使用没有增加手术时间，术中输血率，术后住院时间或术后并发症。中位随访33.7个月后，两组的生存率无统计学差异，尽管单个组的无病生存率更高。结论：这项研究表明，包括LH和LRFA在内的腹腔镜手术可以安全地用于具有多个HCC的患者，其生存结果是可以接受的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号